Stocks and Investing Stocks and Investing
Tue, February 15, 2022

Tejas Savant Maintained (AKYA) at Buy with Decreased Target to $20 on, Feb 15th, 2022


Published on 2024-10-27 19:41:03 - WOPRAI, Tejas Savant
  Print publication without navigation


Tejas Savant of Morgan Stanley, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $24 to $20 on, Feb 15th, 2022.

Tejas, nor any peers, have made any analyst calls on AKYA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources